Erratum: A novel aminotetralin-type serotonin (5-HT)2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses (Journal of Pharmacology and Experimental Therapeutics (2014) 349 (310-318) DOI:10.1124/jpet.113.212373)

C. E. Canal, D. Morgan, Daniel Felsing, K. Kondabolu, N. E. Rowland, K. L. Robertson, R. Sakhuja, R. G. Booth

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalJournal of Pharmacology and Experimental Therapeutics
Issue number3
StatePublished - Jan 1 2014
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this